Cargando…
Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment
Zoledronic acid (ZOL) is a third generation bisphosphonate which can be used as a drug for the treatment of osteoporosis and metastasis. In this study, graphene oxide (GO) is conjugated with ZOL, and the nanostructured material is evaluated in terms viability, proliferation and differentiation. Furt...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211009/ https://www.ncbi.nlm.nih.gov/pubmed/32385391 http://dx.doi.org/10.1038/s41598-020-64760-4 |